Evidence map›Paper›PMID 27877237›Full record

ArticleTheranostics2016

Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery.

Tanner K Hill, Sneha S Kelkar, Nicholas E Wojtynek, Joshua J Souchek, William M Payne, Kristina Stumpf, Frank C Marini, Aaron M Mohs

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Medical Imaging Technology and Imaging Agents.Advances in experimental medicine and biology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Image-guided tumor surgery: The emerging role of nanotechnology.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors.Bioorganic & medicinal chemistry letters · 2019
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tanner K HillDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Sneha S KelkarDepartment of Plastic and Reconstructive Surgery, Wake Forest University Health Sciences, Winston-Salem, NC 27157, United States.
Nicholas E WojtynekFred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Joshua J SouchekDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, United States.
William M PayneDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, United States.
Kristina StumpfWake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC 27157, United States.
Frank C MariniWake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC 27157, United States;; Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, United States.
Aaron M MohsDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, United States;; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, United States.
University of Nebraska Medical Center · USWake Forest University · USForest Institute · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · 1985 to 2026
$55.0M
Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor SurgeryR01EB019449 · NIBIB · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MOHS, AARON M. · 2014 to 2017
$1.3M
Nanotechnology for Minimally Invasive Cancer Detection and ResectionR00CA153916 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MOHS, AARON M. · 2012 to 2014
$708k
Upgrade of mass spectrometer facilityS10RR017846 · NCRR · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI THOMAS, MICHAEL J · 2003 to 2003
$497k
Replacement of GC Mass SpectrometerS10RR027940 · NCRR · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI THOMAS, MICHAEL J · 2010 to 2010
$209k
NCI NIH HHS P30 CA036727NCI NIH HHS R00 CA153916NCRR NIH HHS S10 RR017846NCRR NIH HHS S10 RR027940NIBIB NIH HHS R01 EB019449
6 · The paper itself

Abstract

Tumor tissue that remains undetected at the primary surgical site can cause tumor recurrence, repeat surgery, and treatment strategy alterations that impose a significant patient and healthcare burden. Intraoperative near infrared fluorescence (NIRF) imaging is one potential method to identify remaining tumor by visualization of NIR fluorophores that are preferentially localized to the tumor. This requires development of fluorophores that consistently identify tumor tissue in different patients and tumor types. In this study we examined a panel of NIRF contrast agents consisting of polymeric nanoparticle (NP) formulations derived from hyaluronic acid (HA), with either physically entrapped indocyanine green (ICG) or covalently conjugated Cy7.5. Using orthotopic human breast cancer MDA-MB-231 xenografts in nude mice we identified two lead formulations. One, NanoICG

Indexed as

Infrared RaysAnimalsBreast NeoplasmsContrast MediaDisease Models, AnimalHeterograftsHumansHyaluronic AcidMice, Inbred BALB CMice, NudeNanoparticlesOptical ImagingSurgery, Computer-AssistedContrast MediaHyaluronic Acidnear infrared fluorescence

Identifiers

PMID27877237
PMCPMC5118597
OpenAlexW2555587909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.